SELLAS Life Sciences Group, Inc. (SLS) Social Stream



SELLAS Life Sciences Group, Inc. (SLS): $3.10

-0.08 (-2.36%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SLS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

SELLAS Life Sciences Group Inc (SLS) Price Targets From Analysts

Use the tables below to see what analysts covering SELLAS Life Sciences Group Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-13 2 $21 $18 $19.5 $7.14 173.11%
2021-12-03 2 $21 $16 $18.5 $7.14 159.1%
2022-02-09 2 $21 $15 $17.333 $7.14 142.76%

The Trend in the Analyst Price Target


Over the past 41 weeks, SLS's average price target has gone up $7.33.

Over the past 45 weeks, SLS's average upside potential has been 81.57%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 0 12 8.0 10.000 7.54 32.63%
2021-06-26 0 21 16.5 18.750 13.02 44.01%
2021-07-03 0 21 16.5 18.750 9.10 106.04%
2021-07-24 2 21 16.5 18.500 8.78 110.71%
2022-02-09 2 21 15.0 17.333 6.05 186.5%

SLS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


SLS's average broker recommendation rating improved by 1 over the prior 31 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, SELLAS Life Sciences Group Inc's number of analysts covering the stock is greater than 14.01% of them.
  • In terms of how SELLAS Life Sciences Group Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 342.17% of that group.
  • In terms of how SELLAS Life Sciences Group Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 17.52% of that group.
  • SLS has a greater average analyst price target than 121.25% of Healthcare stocks.

Stocks similar to SELLAS Life Sciences Group Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SLRX, SLGL, and SIGA.

Is SLS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.489 seconds.